Nephrology Dialysis Transplantation

This Article Abstract FREE Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (111) Request Permissions Disclaimer Google Scholar Articles by Duncan, L. Articles by Levin, A. Search for Related Content PubMed PubMed Citation Articles by Duncan, L. Articles by Levin, A. Social Bookmarking          What's this?

Nephrol Dial Transplant (2001) 16: 1042-1046
© 2001 European Renal Association-European Dialysis and Transplant Association

---

Brief Reports

Screening for renal disease using serum creatinine: who are we missing?

Lynda Duncan¹, John Heathcote³, Ognjenka Djurdjev² and Adeera Levin^1,

¹ Division of Nephrology, Department of Medicine and, ² Centre for Health Evaluation & Outcome Sciences (CHEOS), St Paul's Hospital, University of British Columbia, ³ BC Biomedical Laboratories Inc., Vancouver, BC, Canada

	Abstract

Top Abstract Introduction Subjects and methods Results Historical data Discussion References

 
Background. Appropriate management and timely referral of patients with early renal disease often depend on the identification of renal insufficiency by primary care physicians. Serum creatinine (SCr) levels are frequently used as a screening test for renal dysfunction; however, patients can have significantly decreased glomerular filtration rates (GFR) with normal range SCr values, making the recognition of renal dysfunction more difficult. This study was designed to estimate the prevalence of patients who have significantly reduced GFR as calculated by the Cockcroft–Gault (C-G) formula, but normal-range SCr.

Methods. The study included 2781 outpatients referred by community physicians to an urban laboratory network for SCr measurement. GFR was estimated using the C-G formula. Patients were grouped according to the concordance of SCr level abnormalities (abnormal >130 µmol/l) with significantly abnormal C-G values (abnormal 50 ml/min). The C-G value of 50 ml/min was chosen to reflect substantial renal impairment in all age groups. A further analysis of historical laboratory data was undertaken to determine if there were previously documented changes in renal function parameters in those patients who had overt renal dysfunction during the study period.

Results. Of the 2781 outpatients referred, 2543 (91.4%) had normal SCr levels. Of these patients, 387/2543 (15.2%) had C-G calculated GFR 50 ml/min, representing substantially impaired renal function. Among patients with normal SCr, abnormal C-G values were identified in 47.3% 70 years old, 12.6% 60–69 years old, and 1.2% 40–59 years old. Analysis of historical available laboratory data for patients with abnormal SCr and abnormal C-G values showed that 2 years prior to the study period, 72% of this group had abnormal SCr, while 18% had normal SCr with abnormal C-G values, and 10% had normal SCr with normal C-G values.

Conclusions. This study documents the substantial prevalence of significantly abnormal renal function among patients identified by laboratories as having normal-range SCr. Including calculated estimates of GFR in routine laboratory reporting may help to facilitate the early identification of patients with renal impairment.

Keywords: Cockcroft–Gault formula; early renal disease; population; prevention; renal failure; renal function; serum creatinine

	Introduction

Top Abstract Introduction Subjects and methods Results Historical data Discussion References

 
Early identification and appropriate nephrological management of patients with mild renal disease has been increasingly recognized as an important opportunity to delay the progression of renal disease and modify risk factors for comorbid diseases [1–5]. However, early recognition of renal disease and timely referral to nephrologists depend on identification of impaired renal function by primary care physicians. As most patients with mild renal disease are asymptomatic, early detection usually results from an incidental finding on laboratory testing, or routine screening tests targeted at high-risk groups, including patients with diabetes or hypertension.

Many primary care physicians rely on serum creatinine (SCr) as a screening test for renal impairment; however, SCr levels can remain within the normal range even when renal function is significantly impaired [6]. Although not routinely reported by laboratories, a more accurate approximation of renal function can be obtained using formulae, such as the Cockcroft–Gault (C-G) equation [7–10], to calculate an estimated glomerular filtration rate (GFR) from SCr and routine clinical data.

In this study we identified a large outpatient cohort who had had SCr concentrations requested by community physicians. The study was designed to determine the prevalence of patients who had significantly abnormal GFR values (i.e. below any expected age-related declines) as calculated by the C-G equation, but SCr levels within the normal range, which may make the recognition of renal dysfunction more difficult.

	Subjects and methods

Top Abstract Introduction Subjects and methods Results Historical data Discussion References

 
Patients
This cross-sectional study included 2781 outpatients from a large urban area in British Columbia. The study included all patients aged 16 years or older who had had a SCr level ordered by a community physician and measured at the facilities of a single laboratory network during a 14-day period (2–16 July 1998). Patient weights were measured by laboratory staff; genders and birth dates were obtained from health cards. SCr values from the July 1998 visit were used for the primary analysis. Retrospective SCr concentrations were obtained from the laboratory database for previous visits to the laboratory network in the last 4 years. If more than one SCr value was recorded per year, the value closest to year-end was taken to be representative of that year. We screened 2879 patients, and after linkage with the provincial renal databases, patients known to have had a renal transplant or who received dialysis therapy were discarded from the analysis (n=98). Data from physician billing numbers showed that 96% of SCr levels in the study population were ordered by family physicians and general internists. The clinical indications for ordering SCr levels were not available. Additional laboratory testing such as urinalysis was not ordered for most patients and therefore was not included in the analysis. Information regarding the racial background of patients was also not available; however, the local population is primarily Caucasian and Oriental. All data were maintained anonymously.

Laboratory data
SCr levels were measured using the Boehringer–Mannheim Jaffe method on a Hitachi 727 autoanalyser. The normal range for SCr in the laboratory was 30–130 µmol/l. These limits represent the 97.5th percentile of the distribution of SCr levels in healthy male and female volunteers, and were determined using standard laboratory protocols.

Calculations
The C-G formula: (140 -age) (weight in kg)/(SCrx0.81) with a gender correction factor of 0.85 for females, was used to estimate GFR. A stable weight was assumed for calculation of retrospective GFR. Abnormal renal function was very conservatively defined as a calculated GFR 50 ml/min for the purposes of analysis.

Statistical analysis
Patients were divided into four groups based on the concordance of abnormal and normal SCr levels with abnormal and normal GFR as calculated by the C-G formula. The four groups were: normal SCr/normal C-G (overt normal renal function); abnormal SCr/normal C-G (covert normal renal function); normal SCr/abnormal C-G (covert renal dysfunction); abnormal SCr/abnormal C-G (overt renal dysfunction). The group with covert renal dysfunction was the group of primary interest. Descriptive analysis of the population based on age, gender, and laboratory values was performed. Chi square and t-tests were performed on categorical and continuous variables as appropriate.

	Results

Top Abstract Introduction Subjects and methods Results Historical data Discussion References

 
Of the 2781 patients in this outpatient population sent for SCr measurement by community physicians, 2156 (77.5%) had normal SCr concentrations and a normal GFR calculated by the C-G equation, while 182 (6.5%) had overtly abnormal renal function with abnormal SCr and C-G values (Table 1). Interestingly, 443 patients (15.9%) demonstrated discordance between SCr and C-G values, with 387 (13.9%) having normal SCr levels, but C-G values 50 ml/min (covert renal dysfunction). Comparison of the covert renal dysfunction group with the normal SCr/normal C-G group showed statistical difference in SCr levels (99±16 vs 90±14, P<0.001) and C-G values (41±7 vs 85±26, P<0.001).

View this table: [in this window] [in a new window]   Table 1. Demographic characteristics of patients grouped by concordance of serum creatinine (abnormal >130 µmol/l) and C-G values (abnormal 50 ml/min)

 
The demographic characteristics of the patients grouped by concordance of SCr and C-G values are shown in Table 1. The discordance between SCr and C-G-calculated GFR values was most pronounced in the older age groups (Table 2), with 47.3% of patients 70 years or older with normal SCr levels having abnormal C-G values. However, abnormal C-G values were also found in 1.2% of patients in the 40–59 year-old age group with normal SCr levels.

View this table: [in this window] [in a new window]   Table 2. Prevalence of abnormal C-G values (50 ml/min) by age in patients with normal serum creatinine (130 µmol/l)

 

	Historical data

Top Abstract Introduction Subjects and methods Results Historical data Discussion References

 
Analysis of historical laboratory data was undertaken to characterize specifically the ‘renal history’ of patients with overt renal dysfunction (abnormal SCr and abnormal C-G) in 1998. The purpose of this analysis was to determine if these patients had previous abnormalities in renal function, including abnormal C-G values with normal SCr levels, which may have heralded the development of overt kidney dysfunction evident in 1998.

Two-year historical data (1996) was available for 55% of patients (n=100) with overt renal dysfunction in 1998. In 1996, 72% of this group (72 of 100 patients) had abnormal SCr, while 28% (28 of 100) had normal SCr (Table 3). Of the 28% (n=28) with normal SCr in 1996, 36% (10 of 28) had normal C-G values, while 64% (18 of 28) had abnormal C-G values, as defined as 50 ml/min. Thus, over half of the group with normal SCr had abnormal renal function 2 years prior to having abnormal SCr in 1998. Differences in SCr between patients with normal renal function and patients with abnormal renal function (with normal range SCr), are statistically significant (104±15 µmol/l vs 119±9 µmol/l, P=0.003) (Table 4). Similar results were obtained with historical data from 1994, 1995 and 1997 (Tables 3 and 4).

View this table: [in this window] [in a new window]   Table 3. Concordance of previous serum creatinine and C-G values for patients with overt renal dysfunction (abnormal serum creatinine and abnormal C-G values) in 1998

 

View this table: [in this window] [in a new window]   Table 4. Serum creatinine and C-G values for patients with overt renal dysfunction (abnormal serum creatinine and abnormal C-G values) in 1998

 

	Discussion

Top Abstract Introduction Subjects and methods Results Historical data Discussion References

 
Recently there has been increasing emphasis on appropriate treatment and timely referral of patients with early renal disease [1–4]. Serum creatinine is an important screening test for evaluating renal function; however, in this study we found that 13.9% of patients with normal range SCr levels had substantially abnormal calculated GFR, with C-G values 50 ml/min. The significant renal impairment in this group of patients may remain unrecognized by primary care physicians who rely on SCr abnormalities to identify renal insufficiency.

For this study, we chose a very conservative cut-off for abnormal renal function of 50 ml/min to reduce the likelihood of elderly patients being erroneously classified has having abnormal renal function. It has been suggested that renal function decreases over time as part of the normal ageing process [11,12]. However, even with the mean decrease in creatinine clearance of 0.75 ml/min/year found with normal ageing in the Baltimore Longitudinal Study of Aging [11], a normal patient with a GFR of 120 ml/min at age 30 [13] should still have a GFR of >80 ml/min at age 80. Thus ‘abnormal’ renal function in this study (calculated GFR 50 ml/min) is not likely to be solely attributable to normal ageing. Furthermore, there is some data to suggest that those patients with GFR <50 ml/min are at risk of progressive decline in renal function [14]. Thus, our categorization of abnormal renal function using this GFR cut off is rational on that basis as well.

There are limitations to this cross-sectional study. Namely, we were unable to differentiate transient renal dysfunction from early chronic renal insufficiency in the current cohort. Thus, it is unclear what proportion of the group with normal SCr and abnormal C-G values will actually progress to overt renal failure. In an attempt to gain some insight into this issue, we performed a historical review of laboratory data for patients with overt renal dysfunction at the time of the primary study period. In each of the previous 4 years, 10–20% of patients who eventually developed overt renal dysfunction had normal SCr, but C-G values 50 ml/min, representing over half of the patients with normal SCr at these time points. The data therefore suggest that a substantial number of the patients with overt renal dysfunction at the time of the study did indeed pass through a transient stage with abnormal C-G values, but normal SCr levels. This is in keeping with known physiology in that substantial reductions in GFR are necessary before changes in serum creatinine are noted. Clearly, identification of patients in this earlier, transient stage of ‘covert renal dysfunction’ may represent an important opportunity for intervention.

A second shortcoming of our study is the lack of a ‘gold standard’ measurement for GFR, which, due to cost and complexity, is difficult to obtain in a large screening population. We chose the C-G equation to estimate GFR because the equation is well known and requires only readily available laboratory and demographic variables. The C-G formula has previously been shown to correlate well with [^99mTc]-DTPA-measured GFR over the GFR range of 14–100 ml/min, with a correlation coefficient of 1.01, r=0.92 [15]. Couchoud et al. [16] found that the C-G formula somewhat underestimates inulin-clearance-measured GFR in the range of 60–80 ml/min; however, an inulin-clearance cut-off of 60 ml/min/1.73 m², which represents significant renal impairment, could be approximated by a C-G value cut-off of 54±5 ml/min, similar to the cut-off used in this study. While a number of calculations exist to estimate renal function [9,10], none has received the widespread use or recognition of the C-G formula. This is probably due to its ease of use in clinical practice, and reasonable performance in approximating renal function. For the purposes of population screening, this measure then is very useful.

Inexpensive, simple methods of estimating GFR are critical to heighten the awareness of primary care physicians to abnormalities in renal function that exist while SCr remains within the normal range. The current epidemic in the end-stage renal disease population requires identification of patients with kidney disease at a time sufficient to ensure proactive care to delay progression or further damage. There has been recent additional focus on the need for early referral to nephrologists, but this is predicated on the assumption that early renal disease is identifiable by primary care physicians. Nephrologists can help to facilitate this process by emphasizing renal function rather than absolute SCr levels in discussion and guidelines regarding early renal disease. Laboratory reporting, which simplifies identification of abnormal renal function, is another important step towards the appropriate medical management of early progressive renal insufficiency.

	Notes

 
Correspondence and offprint requests to: Adeera Levin MD FRCPC, St Paul's Hospital, 1081 Burrard Street, Room 6010, Vancouver, BC, Canada V6Z 1Y6.

	References

Top Abstract Introduction Subjects and methods Results Historical data Discussion References

 

1. Jungers P. Screening for renal insufficiency: is it worth while? Is it feasible. Nephrol Dial Transplant1999; 14: 2082–2084[Free Full Text]
2. Ismail N, Neyra R, Hakim R. The medical and economical advantages of early referral of chronic renal failure patients to renal specialists. Nephrol Dial Transplant1998; 13: 246–250[Free Full Text]
3. Levin, A. Consequences of late referral on patient outcomes. Nephrol Dial Transplant (in press)
4. Hood SA, Sondheimer JH. Impact of pre-ESRD management on dialysis outcomes: a review. Semin Dial1998; 11: 175–180
5. Culleton BF, Larson MG, Wilson PWF, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int1999; 56: 2214–2219[Web of Science][Medline]
6. Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med1988; 39: 465–490[Web of Science][Medline]
7. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron1976; 16: 31–41[Web of Science][Medline]
8. Campens D, Buntinx F. Selecting the best renal function tests: a meta-analysis of diagnostic studies. Int J Technol Assess Health Care1997; 13: 343–356[Web of Science][Medline]
9. Walser M. Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis1998; 32: 23–31[Web of Science][Medline]
10. Levey, AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med1999; 130: 461–470[Abstract/Free Full Text]
11. Lindeman RD, Tobi J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc1985; 33: 278–285[Web of Science][Medline]
12. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow and tubular excretory capacity in adult males. J Clin Invest1950; 29: 496–507
13. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem1992; 28: 1933–1953
14. Maschio G, Oldrizzi L, Rugiu C. Is there a ‘point of no return’ in progressive renal disease. J Am Soc Nephrol1991; 2: 832–840[Abstract]
15. Cochran M, St John A. A comparison between estimates of GFR using [^99mTc]DTPA clearance and the approximation of Cockcroft and Gault. Aust NZ J Med1993; 23: 494–497[Web of Science][Medline]
16. Couchoud C, Pozet N, Labeux M, Pouteil-Nobel C. Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int1999; 55: 1878–1884[Web of Science][Medline]

Received for publication: 26. 6.00
Revision received 15.12.00.
CiteULike    Connotea    Del.icio.us    What's this?

This article has been cited by other articles:

				E. Terpos, E. Katodritou, E. Tsiftsakis, E. Kastritis, D. Christoulas, A. Pouli, E. Michalis, E. Verrou, K. Anargyrou, K. Tsionos, et al. Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration Haematologica, March 1, 2009; 94(3): 372 - 379. [Abstract] [Full Text] [PDF]

				M. Najafi, H. Goodarzynejad, A. Karimi, A. Ghiasi, H. Soltaninia, M. Marzban, A. Salehiomran, B. Alinejad, and M. Soleymanzadeh Is preoperative serum creatinine a reliable indicator of outcome in patients undergoing coronary artery bypass surgery? J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 304 - 308. [Abstract] [Full Text] [PDF]

				J. R. den Hartog, P. P. Reese, B. Cizman, and H. I. Feldman The Costs and Benefits of Automatic Estimated Glomerular Filtration Rate Reporting Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 419 - 427. [Abstract] [Full Text] [PDF]

				R. Morriss and B. Benjamin Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease The British Journal of Psychiatry, August 1, 2008; 193(2): 93 - 95. [Abstract] [Full Text] [PDF]

				B. R. Herts, E. Schneider, E. D. Poggio, N. A. Obuchowski, and M. E. Baker Identifying Outpatients with Renal Insufficiency before Contrast-enhanced CT by Using Estimated Glomerular Filtration Rates versus Serum Creatinine Levels Radiology, July 1, 2008; 248(1): 106 - 113. [Abstract] [Full Text] [PDF]

				J. L. Carter, S. E. O'Riordan, G. L. Eaglestone, M. P. Delaney, and E. J. Lamb Chronic kidney disease prevalence in a UK residential care home population Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1257 - 1264. [Abstract] [Full Text] [PDF]

				M. A. Ikram, M. W. Vernooij, A. Hofman, W. J. Niessen, A. van der Lugt, and M. M.B. Breteler Kidney Function Is Related to Cerebral Small Vessel Disease Stroke, January 1, 2008; 39(1): 55 - 61. [Abstract] [Full Text] [PDF]

				C. E. Lok, D. Appleton, C. Bhola, B. Khoo, and R. M. A. Richardson Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters Nephrol. Dial. Transplant., February 1, 2007; 22(2): 477 - 483. [Abstract] [Full Text] [PDF]

				W. F. Clark, J. J. Macnab, S. J. Chen, R. Suri, L. Moist, and A. X. Garg Evaluation of GFR Estimating Equations in the General Community: Implications for Screening Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 787 - 795. [Abstract] [Full Text] [PDF]

				E. A van Dijk, N. R. Drabbe, M. Kruijtbosch, and P. A. De Smet Drug Dosage Adjustments According to Renal Function at Hospital Discharge Ann. Pharmacother., July 1, 2006; 40(7): 1254 - 1260. [Abstract] [Full Text] [PDF]

				B. M. Elicker, Y. S. Cypel, and J. C. Weinreb IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. Am. J. Roentgenol., June 1, 2006; 186(6): 1651 - 1658. [Abstract] [Full Text] [PDF]

				L. Noyez, I. Plesiewicz, and F. W.A. Verheugt Estimated creatinine clearance instead of plasma creatinine level as prognostic test for postoperative renal function in patients undergoing coronary artery bypass surgery. Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 461 - 465. [Abstract] [Full Text] [PDF]

				L. A. Stevens, G. Fares, J. Fleming, D. Martin, K. Murthy, J. Qiu, P. C. Stark, K. Uhlig, F. Van Lente, and A. S. Levey Low Rates of Testing and Diagnostic Codes Usage in a Commercial Clinical Laboratory: Evidence for Lack of Physician Awareness of Chronic Kidney Disease J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2439 - 2448. [Abstract] [Full Text] [PDF]

				G. Asimakopoulos, A. P. Karagounis, O. Valencia, N. Alexander, M. Howlader, M. A. Sarsam, and V. Chandrasekaran Renal Function After Cardiac Surgery Off- Versus On-Pump Coronary Artery Bypass: Analysis Using the Cockroft-Gault Formula for Estimating Creatinine Clearance Ann. Thorac. Surg., June 1, 2005; 79(6): 2024 - 2031. [Abstract] [Full Text] [PDF]

				E. J. Lamb, H. J. Stowe, D. E. Simpson, A. J. Coakley, D. J. Newman, and M. Leahy Diagnostic Accuracy of Cystatin C as a Marker of Kidney Disease in Patients with Multiple Myeloma: Calculated Glomerular Filtration Rate Formulas Are Equally Useful Clin. Chem., October 1, 2004; 50(10): 1848 - 1851. [Full Text] [PDF]

				A. Akbari, P. J. Swedko, H. D. Clark, W. Hogg, J. Lemelin, P. Magner, L. Moore, and D. Ooi Detection of Chronic Kidney Disease With Laboratory Reporting of Estimated Glomerular Filtration Rate and an Educational Program Arch Intern Med, September 13, 2004; 164(16): 1788 - 1792. [Abstract] [Full Text] [PDF]

				G. C. Curhan, E. L. Knight, B. Rosner, S. E. Hankinson, and M. J. Stampfer Lifetime Nonnarcotic Analgesic Use and Decline in Renal Function in Women Arch Intern Med, July 26, 2004; 164(14): 1519 - 1524. [Abstract] [Full Text] [PDF]

				C. L Long, M. A Raebel, D. W Price, and D. J Magid Compliance with Dosing Guidelines in Patients with Chronic Kidney Disease Ann. Pharmacother., May 1, 2004; 38(5): 853 - 858. [Abstract] [Full Text] [PDF]

				F. Wang, J.-Y. Dupuis, H. Nathan, and K. Williams An Analysis of the Association Between Preoperative Renal Dysfunction and Outcome in Cardiac Surgery: Estimated Creatinine Clearance or Plasma Creatinine Level as Measures of Renal Function,* Chest, November 1, 2003; 124(5): 1852 - 1862. [Abstract] [Full Text] [PDF]

				J. B. Ashley and S. F. Millward Contrast Agent-Induced Nephropathy: A Simple Way to Identify Patients with Preexisting Renal Insufficiency Am. J. Roentgenol., August 1, 2003; 181(2): 451 - 454. [Full Text] [PDF]

				S. J. Chadban, E. M. Briganti, P. G. Kerr, D. W. Dunstan, T. A. Welborn, P. Z. Zimmet, and R. C. Atkins Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S131 - 138. [Abstract] [Full Text] [PDF]

				P. J. Swedko, H. D. Clark, K. Paramsothy, and A. Akbari Serum Creatinine Is an Inadequate Screening Test for Renal Failure in Elderly Patients Arch Intern Med, February 10, 2003; 163(3): 356 - 360. [Abstract] [Full Text] [PDF]

				E. J. Kingdon, C. J. Knight, K. Dustan, A. G. Irwin, M. Thomas, S. H. Powis, A. Burns, A. J. W. Hilson, and C. M. Black Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment Rheumatology, January 1, 2003; 42(1): 26 - 33. [Abstract] [Full Text] [PDF]

				C. M. Clase, A. X. Garg, and B. A. Kiberd Prevalence of Low Glomerular Filtration Rate in Nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III) J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1338 - 1349. [Abstract] [Full Text] [PDF]

This Article Abstract FREE Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (111) Request Permissions Disclaimer Google Scholar Articles by Duncan, L. Articles by Levin, A. Search for Related Content PubMed PubMed Citation Articles by Duncan, L. Articles by Levin, A. Social Bookmarking          What's this?

Online ISSN 1460-2385 - Print ISSN 0931-0509

Copyright © 2009 European Renal Association - European Dialysis and Transplant Assoc

Oxford Journals Oxford University Press

• Site Map
• Privacy Policy
• Frequently Asked Questions

Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics